Package 71610-866-60

{"route": ["ORAL"], "spl_id": "d103c1fe-4d4c-48e2-8e30-494b19dd7e52", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["d0eada89-e302-4ba3-bef0-e8c69af8206e"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-866-53)", "package_ndc": "71610-866-53", "marketing_start_date": "20241121"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-866-60)", "package_ndc": "71610-866-60", "marketing_start_date": "20241121"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-866-70)", "package_ndc": "71610-866-70", "marketing_start_date": "20241121"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-866-80)", "package_ndc": "71610-866-80", "marketing_start_date": "20241121"}], "brand_name": "bupropion Hydrochloride", "product_id": "71610-866_d103c1fe-4d4c-48e2-8e30-494b19dd7e52", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-866", "generic_name": "bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA206975", "marketing_category": "ANDA", "marketing_start_date": "20160819", "listing_expiration_date": "20261231"}